ES2268133T3 - Derivados de quinolina, procedimientos de preparacion y su uso para el tratamiento de enfermedades mediadas por s-cd3. - Google Patents
Derivados de quinolina, procedimientos de preparacion y su uso para el tratamiento de enfermedades mediadas por s-cd3. Download PDFInfo
- Publication number
- ES2268133T3 ES2268133T3 ES02790436T ES02790436T ES2268133T3 ES 2268133 T3 ES2268133 T3 ES 2268133T3 ES 02790436 T ES02790436 T ES 02790436T ES 02790436 T ES02790436 T ES 02790436T ES 2268133 T3 ES2268133 T3 ES 2268133T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- formula
- baselineskip
- procedure
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0128378 | 2001-11-27 | ||
| GBGB0128378.7A GB0128378D0 (en) | 2001-11-27 | 2001-11-27 | Novel Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2268133T3 true ES2268133T3 (es) | 2007-03-16 |
Family
ID=9926525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02790436T Expired - Lifetime ES2268133T3 (es) | 2001-11-27 | 2002-11-25 | Derivados de quinolina, procedimientos de preparacion y su uso para el tratamiento de enfermedades mediadas por s-cd3. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7045626B2 (enExample) |
| EP (1) | EP1448552B1 (enExample) |
| JP (1) | JP2005513036A (enExample) |
| AR (1) | AR037427A1 (enExample) |
| AT (1) | ATE334124T1 (enExample) |
| AU (1) | AU2002365511A1 (enExample) |
| DE (1) | DE60213450T2 (enExample) |
| ES (1) | ES2268133T3 (enExample) |
| GB (1) | GB0128378D0 (enExample) |
| TW (1) | TW200303745A (enExample) |
| WO (1) | WO2003045938A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080083071A (ko) | 2003-08-08 | 2008-09-12 | 아지노모토 가부시키가이샤 | 나테글리니드 함유 제제 |
| ES2619829T3 (es) | 2011-11-18 | 2017-06-27 | Heptares Therapeutics Limited | Agonistas del receptor muscarínico M1 |
| US9593106B2 (en) | 2013-02-07 | 2017-03-14 | Heptares Therapeutics Limited | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1001930T3 (da) | 1997-07-31 | 2003-03-24 | Abbott Lab | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser |
| DE69934094T2 (de) | 1998-01-30 | 2007-06-06 | Darwin Discovery Ltd., Slough | N-hydroxyformamid-derivate |
-
2001
- 2001-11-27 GB GBGB0128378.7A patent/GB0128378D0/en not_active Ceased
-
2002
- 2002-11-25 ES ES02790436T patent/ES2268133T3/es not_active Expired - Lifetime
- 2002-11-25 US US10/496,193 patent/US7045626B2/en not_active Expired - Fee Related
- 2002-11-25 JP JP2003547388A patent/JP2005513036A/ja active Pending
- 2002-11-25 AR ARP020104526A patent/AR037427A1/es not_active Application Discontinuation
- 2002-11-25 EP EP02790436A patent/EP1448552B1/en not_active Expired - Lifetime
- 2002-11-25 AT AT02790436T patent/ATE334124T1/de not_active IP Right Cessation
- 2002-11-25 WO PCT/EP2002/013264 patent/WO2003045938A1/en not_active Ceased
- 2002-11-25 AU AU2002365511A patent/AU2002365511A1/en not_active Abandoned
- 2002-11-25 TW TW091134147A patent/TW200303745A/zh unknown
- 2002-11-25 DE DE60213450T patent/DE60213450T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005513036A (ja) | 2005-05-12 |
| AU2002365511A1 (en) | 2003-06-10 |
| EP1448552A1 (en) | 2004-08-25 |
| US7045626B2 (en) | 2006-05-16 |
| GB0128378D0 (en) | 2002-01-16 |
| DE60213450D1 (de) | 2006-09-07 |
| WO2003045938A1 (en) | 2003-06-05 |
| AR037427A1 (es) | 2004-11-10 |
| EP1448552B1 (en) | 2006-07-26 |
| US20050085505A1 (en) | 2005-04-21 |
| TW200303745A (en) | 2003-09-16 |
| DE60213450T2 (de) | 2007-09-20 |
| ATE334124T1 (de) | 2006-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8008341B2 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases | |
| CN103958505B (zh) | 用于治疗趋化因子介导的病理的二取代的3,4-二氨基-3-环丁烯-1,2-二酮化合物 | |
| EP1811993A2 (en) | Modulators of crth2, cox-2 and faah | |
| CN101379059A (zh) | N-羟基丙烯酰胺化合物 | |
| ES2205218T3 (es) | Inhibidores de la produccion de la s-cd23 y de la secrecion de factor de necrosis de tumores (fnt). | |
| US7045626B2 (en) | Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23 | |
| JP2003532727A (ja) | Ｃｄ２３の阻害剤としてのｎ−スルホニルヒドロキサム酸誘導体 | |
| ES2222711T3 (es) | Derivados de acido hidroxamico como inhibidores de la produccion de cd23 humano y de la liberacion de tnf. | |
| AU725056B2 (en) | Hydroxamic acid based collagenase inhibitors | |
| JP3922431B2 (ja) | 可溶性ヒトｃｄ２３形成阻害剤としてのヒドロキサム酸誘導体 | |
| CN114746087A (zh) | 新的经取代的亚砜亚胺衍生物 | |
| ES2243783T3 (es) | Derivados de sulfona apropiadas para el tratamiento de enfermedades autoinmunes y alergias. | |
| US20060247271A1 (en) | Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23 | |
| HK1035894B (en) | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release | |
| HK1035894A (en) | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release | |
| WO2001044221A1 (en) | Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release | |
| CZ20004818A3 (cs) | Deriváty kyseliny hydroxamové jako inhibitory produkce lidské CD23 a uvolňování TNF | |
| HK1049146B (en) | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 | |
| MXPA00012854A (en) | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and ofthe tnf release |